A handful of antibiotics can interact with Eliquis (apixaban), either raising your bleeding risk or making the medication less effective at preventing blood clots. The most clinically significant interactions involve clarithromycin, erythromycin, and rifampin. Most common antibiotics, including standard penicillins and cephalosporins, do not interact with Eliquis through its known metabolic pathways.
How Eliquis Gets Processed in Your Body
Eliquis is broken down through two systems that matter for drug interactions. The first is a liver enzyme called CYP3A4, which helps metabolize the drug. The second is a transport protein called P-glycoprotein (P-gp), which acts like a gatekeeper in your gut wall, pumping drugs back out before they fully absorb into your bloodstream.
Any antibiotic that strongly blocks both of these systems at once can cause Eliquis to build up in your blood, increasing bleeding risk. Conversely, an antibiotic that revs up both systems can flush Eliquis out faster than normal, leaving you underprotected against clots. This dual-pathway vulnerability is the key to understanding which antibiotics cause problems.
Clarithromycin: The Highest-Risk Antibiotic
Clarithromycin (Biaxin) is a macrolide antibiotic commonly prescribed for respiratory and sinus infections. It is both a strong CYP3A4 inhibitor and a P-gp inhibitor, which means it hits both pathways Eliquis depends on. A large study published in the Journal of the American Heart Association found that patients taking a direct oral anticoagulant alongside clarithromycin had nearly five times the risk of gastrointestinal bleeding (hazard ratio of 4.98) and roughly four times the risk of hospitalization for major bleeding (hazard ratio of 4.18) compared to those not taking the combination.
Interestingly, the FDA prescribing label for Eliquis states that pharmacokinetic data suggest no dose adjustment is necessary when clarithromycin is used alongside apixaban. This creates a confusing situation: the drug label says the blood levels don’t change enough to warrant a dose cut, but real-world patient data shows a substantially higher bleeding rate. Because of this gap, many clinicians prefer to use a different antibiotic when possible for patients on Eliquis.
Erythromycin: A Moderate Concern
Erythromycin is another macrolide antibiotic that inhibits CYP3A4 and P-gp, though less potently than clarithromycin. In the same large study, erythromycin showed a trend toward increased gastrointestinal bleeding (hazard ratio of 2.46) and major bleeding hospitalizations (hazard ratio of 2.05), but these results did not reach statistical significance, meaning the data wasn’t strong enough to confirm the risk definitively. Still, erythromycin is generally treated with caution in patients on Eliquis, and alternatives are often preferred when available.
Rifampin: The Opposite Problem
Rifampin (Rifadin) is used to treat tuberculosis and certain other serious infections. Unlike clarithromycin, rifampin is a powerful inducer of both CYP3A4 and P-gp. Instead of raising Eliquis levels, it dramatically lowers them. In a pharmacokinetic study, rifampin reduced the total amount of apixaban absorbed into the bloodstream by about 54%, and lowered peak blood concentrations by roughly 42%.
At those levels, Eliquis may not provide adequate protection against stroke or blood clots. The FDA label is direct on this point: avoid using Eliquis with rifampin. If you need rifampin for a serious infection like tuberculosis, your doctor will likely switch you to a different type of anticoagulant for the duration of treatment. This isn’t a situation where a simple dose adjustment fixes the problem.
Azithromycin and Other Macrolides
Azithromycin (Z-Pack) is often discussed as a safer alternative to clarithromycin for patients on Eliquis. It inhibits P-gp but is not a strong CYP3A4 inhibitor, so it only affects one of the two pathways. A retrospective study comparing clarithromycin to azithromycin in patients on direct oral anticoagulants found that clarithromycin carried a higher incidence of hospitalization for major bleeding. This makes azithromycin a reasonable option when a macrolide antibiotic is needed, though it still warrants some awareness.
Antibiotics With No Known Interaction
Most antibiotics you’re likely to encounter for everyday infections don’t meaningfully affect CYP3A4 or P-gp activity. Standard penicillins (like amoxicillin), cephalosporins (like cephalexin), and common urinary tract infection antibiotics like nitrofurantoin and trimethoprim do not operate through these pathways. If your doctor has a choice of antibiotic for a routine infection, these classes are generally straightforward options while you’re on Eliquis.
Fluoroquinolones like ciprofloxacin and levofloxacin are also not strong CYP3A4 or P-gp inhibitors. However, fluoroquinolones carry their own set of side effects and warnings unrelated to Eliquis, so they’re typically reserved for infections where other options won’t work.
Fluconazole: Not an Antibiotic, but Worth Knowing
Fluconazole is an antifungal, not an antibiotic, but it often comes up in this conversation because it’s frequently prescribed alongside antibiotics or for infections that patients might lump together. The same Journal of the American Heart Association study found fluconazole was associated with roughly 2.4 times the risk of both gastrointestinal bleeding and major bleeding hospitalization in patients on direct oral anticoagulants. If you’re prescribed an antifungal while on Eliquis, this is one to flag with your pharmacist.
Warning Signs of an Interaction
If you start a new antibiotic while taking Eliquis, watch for signs that your blood is thinning too much. The clearest signals are unusual bruising, bleeding gums, nosebleeds that are hard to stop, blood in your urine (which may look pink or red), and black or tarry stools, which indicate bleeding in your digestive tract. Vomiting material that looks like coffee grounds is another red flag.
Less obvious signs include feeling unusually dizzy, confused, or fatigued without a clear explanation. Prolonged bleeding from minor cuts, heavier menstrual periods, or red spots appearing in the whites of your eyes all suggest excessive anticoagulation. These symptoms can emerge within the first few days of starting an interacting antibiotic, since enzyme inhibitors tend to take effect quickly.
On the flip side, if you’re taking something like rifampin that lowers Eliquis levels, you won’t feel the interaction happening. The danger is silent: your clot protection drops without any noticeable symptoms until a clot actually forms. That’s why the FDA recommendation is to avoid the combination entirely rather than try to monitor for problems.
Quick Reference by Risk Level
- Avoid with Eliquis: Rifampin (dramatically lowers Eliquis levels, increasing clot risk)
- Use with caution: Clarithromycin (associated with up to 5x increased bleeding risk in observational data), erythromycin (trend toward increased bleeding, less certain)
- Lower concern: Azithromycin (affects only one metabolic pathway, lower bleeding signal than clarithromycin)
- No known interaction: Amoxicillin, cephalosporins, nitrofurantoin, trimethoprim, and most other common antibiotics